Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
Martin S. Weber(Fraunhofer Institute for Translational Medicine and Pharmacology), Scott S. Zamvil(University of California, San Francisco), Olaf Stüve(The University of Texas Southwestern Medical Center), Sawsan Youssef(Stanford University), Juan C. Patarroyo(University of California, San Francisco), Lawrence Steinman(Stanford University), Raymond A. Sobel(Stanford University), Linda Lee(Purdue University West Lafayette), Cynthia D Rundle(University of California, San Francisco), Thomas Prod’homme(University of California, San Francisco), Shannon E. Dunn(Stanford University)
Cited by 448
Related Papers
Defining Translational Research: Implications for Training
|Academic Medicine|2010|670
The Occurence of C–H · · · O Hydrogen Bonds in Proteins
|Journal of Molecular Biology|1995|568
Sorption of Three Tetracyclines by Several Soils: Assessing the Role of pH and Cation Exchange
|Environmental Science & Technology|2005|518
1,25-Dihydroxyvitamin D <sub>3</sub> Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
|Molecular and Cellular Biology|2011|456